Bufenadrine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C21H29NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9Y0T619B3U, chemically known as 2-((o-tert-butyl-alpha-phenyl-benzyl)oxy)-n,n-dimethylethylamine. but generally known as bufenadrine, which bears US NIH Compound Identifier 21916. European Medicines Agency schedules Bufenadrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05959MIG. The term BUFENADRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). BUFENADRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bufenadrine under HS 29221980 and SITC 51461. As of Q4 2014, BUFENADRINE remains the US FDA Preferred Term for this commodity. Bufenadrine bears US NLM identifiers UMLS ID C2347227 and NCI Concept Code C73046. SMILES: O(C(C1C(C(C)(C)C)CCCC1)C1CCCCC1)CCN(C)C.